These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 34729994)

  • 21. Vitamin K Intake and Atherosclerotic Cardiovascular Disease in the Danish Diet Cancer and Health Study.
    Bellinge JW; Dalgaard F; Murray K; Connolly E; Blekkenhorst LC; Bondonno CP; Lewis JR; Sim M; Croft KD; Gislason G; Torp-Pedersen C; Tjønneland A; Overvad K; Hodgson JM; Schultz C; Bondonno NP
    J Am Heart Assoc; 2021 Aug; 10(16):e020551. PubMed ID: 34369182
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relationship between serum lipid concentrations and impaired renal function in patients with chronic kidney disease: the Fukuoka Kidney Disease Registry Study.
    Nakano T; Tanaka S; Tsuruya K; Kitazono T
    Clin Exp Nephrol; 2021 Apr; 25(4):385-393. PubMed ID: 33398604
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial.
    Charytan DM; Sabatine MS; Pedersen TR; Im K; Park JG; Pineda AL; Wasserman SM; Deedwania P; Olsson AG; Sever PS; Keech AC; Giugliano RP;
    J Am Coll Cardiol; 2019 Jun; 73(23):2961-2970. PubMed ID: 31196453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Longitudinal Plasma Measures of Trimethylamine N-Oxide and Risk of Atherosclerotic Cardiovascular Disease Events in Community-Based Older Adults.
    Lee Y; Nemet I; Wang Z; Lai HTM; de Oliveira Otto MC; Lemaitre RN; Fretts AM; Sotoodehnia N; Budoff M; DiDonato JA; McKnight B; Tang WHW; Psaty BM; Siscovick DS; Hazen SL; Mozaffarian D
    J Am Heart Assoc; 2021 Sep; 10(17):e020646. PubMed ID: 34398665
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Associations between lower levels of low-density lipoprotein cholesterol and cardiovascular events in very high-risk patients: Pooled analysis of nine ODYSSEY trials of alirocumab versus control.
    Vallejo-Vaz AJ; Ray KK; Ginsberg HN; Davidson MH; Eckel RH; Lee LV; Bessac L; Pordy R; Letierce A; Cannon CP
    Atherosclerosis; 2019 Sep; 288():85-93. PubMed ID: 31349086
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lowering Targeted Atherogenic Lipoprotein Cholesterol Goals for Patients at "Extreme" ASCVD Risk.
    Rosenblit PD
    Curr Diab Rep; 2019 Nov; 19(12):146. PubMed ID: 31754844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibroblast growth factor-23 and cardiovascular events in CKD.
    Scialla JJ; Xie H; Rahman M; Anderson AH; Isakova T; Ojo A; Zhang X; Nessel L; Hamano T; Grunwald JE; Raj DS; Yang W; He J; Lash JP; Go AS; Kusek JW; Feldman H; Wolf M;
    J Am Soc Nephrol; 2014 Feb; 25(2):349-60. PubMed ID: 24158986
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid profiles and risk of major adverse cardiovascular events in CKD and diabetes: A nationwide population-based study.
    Lee Y; Park S; Lee S; Kim Y; Kang MW; Cho S; Park S; Han K; Kim YC; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
    PLoS One; 2020; 15(4):e0231328. PubMed ID: 32271842
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.
    Emrich IE; Zawada AM; Martens-Lobenhoffer J; Fliser D; Wagenpfeil S; Heine GH; Bode-Böger SM
    Clin Res Cardiol; 2018 Mar; 107(3):201-213. PubMed ID: 29101459
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular risk prediction in chronic kidney disease patients.
    Cedeño Mora S; Goicoechea M; Torres E; Verdalles Ú; Pérez de José A; Verde E; García de Vinuesa S; Luño J
    Nefrologia; 2017; 37(3):293-300. PubMed ID: 28495396
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimation of Atherosclerotic Cardiovascular Disease Risk Among Patients in the Veterans Affairs Health Care System.
    Vassy JL; Lu B; Ho YL; Galloway A; Raghavan S; Honerlaw J; Tarko L; Russo J; Qazi S; Orkaby AR; Tanukonda V; Djousse L; Gaziano JM; Gagnon DR; Cho K; Wilson PWF
    JAMA Netw Open; 2020 Jul; 3(7):e208236. PubMed ID: 32662843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Triglyceride-Rich Lipoproteins, Apolipoproteins, and Atherosclerotic Cardiovascular Events Among Patients with Diabetes Mellitus and End-Stage Renal Disease on Hemodialysis.
    Lamprea-Montealegre JA; Katz R; Scharnagl H; Silbernagel G; März W; Drechsler C; Wanner C; de Boer IH
    Am J Cardiol; 2021 Aug; 152():63-68. PubMed ID: 34108090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD.
    Tuegel C; Katz R; Alam M; Bhat Z; Bellovich K; de Boer I; Brosius F; Gadegbeku C; Gipson D; Hawkins J; Himmelfarb J; Ju W; Kestenbaum B; Kretzler M; Robinson-Cohen C; Steigerwalt S; Bansal N
    Am J Kidney Dis; 2018 Oct; 72(4):519-528. PubMed ID: 29866459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiorenal care coordination: holistic patient care opportunities in the primary care setting for patients with chronic kidney disease and atherosclerotic cardiovascular disease.
    Miller E; Raj D; Cavender MA; Mehanna S; Namvar T; Ochsner R
    Postgrad Med; 2023 Sep; 135(7):708-716. PubMed ID: 37691591
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recreational substance use among patients with premature atherosclerotic cardiovascular disease.
    Mahtta D; Ramsey D; Krittanawong C; Al Rifai M; Khurram N; Samad Z; Jneid H; Ballantyne C; Petersen LA; Virani SS
    Heart; 2021 Apr; 107(8):650-656. PubMed ID: 33589427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On-treatment lipid profiles to predict the cardiovascular outcomes in ASCVD patients comorbid with chronic kidney disease - The multi-center T-SPARCLE registry study.
    Ho LT; Lin FJ; Tseng WK; Yin WH; Wu YW; Li YH; Yeh HI; Chen JW; Wu CC;
    J Formos Med Assoc; 2018 Sep; 117(9):814-824. PubMed ID: 29945742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between intensity of statin therapy and mortality in persons with chronic kidney disease.
    Walther CP; Richardson PA; Virani SS; Winkelmayer WC; Navaneethan SD
    Nephrol Dial Transplant; 2020 Feb; 35(2):312-319. PubMed ID: 30053252
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypertriglyceridemia in statin-treated US adults: the National Health and Nutrition Examination Survey.
    Fan W; Philip S; Granowitz C; Toth PP; Wong ND
    J Clin Lipidol; 2019; 13(1):100-108. PubMed ID: 30594443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Central obesity and incident atherosclerotic cardiovascular disease events in hemodialysis patients.
    Lin TY; Hung SC; Lim PS
    Nutr Metab Cardiovasc Dis; 2020 Mar; 30(3):500-507. PubMed ID: 31831366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atherosclerotic Cardiovascular Disease Events in Adults With CKD Taking a Moderate- or High-Intensity Statin: The Chronic Renal Insufficiency Cohort (CRIC) Study.
    Poudel B; Rosenson RS; Bittner V; Gutiérrez OM; Anderson AH; Woodward M; Deo R; Carson AP; Mues KE; Dluzniewski PJ; Jaar BG; Lora CM; Taliercio J; Muntner P; Colantonio LD;
    Kidney Med; 2021; 3(5):722-731.e1. PubMed ID: 34693254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.